BPC-157 vs Kratom for pain & inflammation
Short answer: For pain & inflammation, more users report improvement with Kratom — 93% of 28 reports, versus 84% of 377 for BPC-157.
BPC-157 has 0 meta-analyses and 0 randomized trials on PubMed; Kratom has 18 and 5.
Based on 1,171 reports about BPC-157 and 421 about Kratom. Not medical advice.
| BPC-157 Peptide | Kratom Substance | |
|---|---|---|
| User score | 47 | 50 |
| Verdict | Mixed | Mixed |
| Positive of reports that state an outcome | 53% | 42% |
| Reports | 1,171 | 421 |
| Research | DResearch: None | BResearch: Moderate |
| Meta-analyses / RCTs | 0 / 0 | 18 / 5 |
| Mainly used for | ||
| Weight loss % reporting improvement | 70% (10) | 50% (2) |
| Appetite % reporting improvement | 70% (10) | 100% (3) |
| Focus % reporting improvement | 64% (28) | 77% (31) |
| Energy % reporting improvement | 59% (29) | 78% (54) |
| Sleep % reporting improvement | 71% (52) | 71% (7) |
| Anxiety % reporting improvement | 44% (57) | 86% (69) |
| Mood % reporting improvement | 58% (106) | 85% (97) |
| Memory % reporting improvement | 33% (3) | 0% (5) |
| Performance % reporting improvement | 93% (44) | 100% (3) |
| Recovery % reporting improvement | 96% (342) | — |
| Pain & inflammation % reporting improvement | 84% (377) | 93% (28) |
| Digestion % reporting improvement | 82% (90) | 33% (9) |
| Libido % reporting improvement | 54% (13) | 0% (12) |
| Hormones % reporting improvement | 20% (5) | 22% (9) |
| Heart & lipids % reporting improvement | 46% (13) | — |
| Skin & hair % reporting improvement | 89% (27) | — |
| Immunity % reporting improvement | 62% (8) | — |
| Common side effects | anhedonia, fatigue, anxiety, depression | withdrawal, dependence, addiction, tolerance |
| Typical dose reported | Not listed | 4 g / 2x daily |
BPC-157Full BPC-157 profile →
What a user said
“after 2+ years of nothing working, this is the 1st thing to reverse significant muscle damage ... 40% increase in my range of motion, and nearly the same in muscle strength.”
KratomFull Kratom profile →
Latest review conclusion
Based on our analysis, patients using <20 g of kratom/d could be initiated on opioid agonist therapy with 4/1 mg-8/2 mg buprenorphine-naloxone/d, while patients using kratom doses >40 g/d could be initiated with 12/3 mg-16/4 mg of buprenorphine-naloxone/day.
J Addict Med, 2021 ↗What a user said
“Green or white Kratom powder. My productivity and overall mood have skyrocketed. I dose 4 grams once per day and it’s worked wonders.”
Related comparisons
Percentages come from first-hand user reports and are not clinical outcomes. Talk to a doctor before starting, stopping or combining anything. How we rate